EG&S is representing Fig Publishing, Inc. in Fig's ongoing, multiple securities offerings under the SEC's amended Regulation A. Fig is a video game publisher that issues separate series of preferred stock to members of the public, with each series designed to pay dividends based on revenues earned from a separate video game. So far, Fig has sold three series of Regulation A "Fig Game Shares".
Client Alert: New York City Bans All Inquiries Regarding Salary Histories of Job Applicants
New York City has joined other states and cities across the country – including Massachusetts and Philadelphia – in banning employers from inquiring about a job candidate's salary history. Per legislation signed on May 4, 2017 by New York City Mayor Bill DeBlasio, effective November 1, 2017, all employers in New York City, both public and private and regardless of size, may no longer:
(1) inquire about the salary history of an applicant for employment; or
(2) rely on the salary history of an applicant in determining that applicant's salary at any stage in the employment process, unless the applicant "unprompted" and "willingly" discloses his or her prior salary information.
Amyris Inc. announced the closing of their Registered Direct offering in the amount of $87,343,875. EG&S acted as counsel to the Placement Agent.
On April 26, 2017, the Appellate Division, Second Department issued a decision reversing the Surrogate of Rockland County who had previously granted petitioner's motion for summary judgment against EGS client, Alfred Zucaro. In reversing, the Second Department also granted Mr. Zucaro summary judgment dismissing petitioner's conversion cause of action against him.
James K. Landau, a member of the Firm, represented Mr. Zucaro in connection with the appeal. A copy of the decision can be found at http://law.justia.com/cases/new-york/appellate-division-second-department/2017/2015-02684.html.
The Deal issued its quarterly PIPE league tables, revealing that 2017's first quarter outperformed last year's first quarter. Deals were up nearly 75% from the previous year to 367, while dollars raised were up almost 70% to $21.3 billion.
EG&S is top ranked. Click here to read the article.
CytRx Corporation announced the closing of their Registered Direct in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
BioPharm X Corporation announced the closing of their Registered Direct offering in the amount of $5,000,001. EG&S acted as counsel to the lead Investor.
Aeterna Zentaris Inc. announced the implementation of their At the Market offering in the amount of $6,944,000. EG&S acted as counsel to the Placement Agent.
Apricus Biosciences, Inc. announced the closing of their Underwritten offering in the amount of $7,042,000. EG&S acted as counsel to the Underwriter.
Sunshine Heart, Inc. announced the closing of their Underwritten offering in the amount of $8,372,000. EG&S acted as counsel to the Underwriter.
Social Reality Inc. announced the closing of their PIPE offering in the amount of $5,000,000. EG&S acted as counsel to the lead Investor.
DelMar Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
SkyPeople Fruit Juice, Inc. announced the closing of their Registered Direct offering in the amount of $2,672,500. EG&S acted as counsel to the Placement Agent.
Cytori Therapeutics announced the closing of a confidentially marketed public offering of common stock in the amount of $8.8 million. EG&S acted as counsel to the underwriter, Maxim Group LLC.
Forum Merger Corporation, a company formed for the purpose of entering into a merger, share exchange, asset acquisition or other similar business combination with one or more businesses or entities, announced the closing of its initial public offering in the amount of $150,000,000. EG&S acted as counsel to Forum Merger.
Blink Health announced that it has raised a $90 million Series B equity funding led by 8VC, bringing its total venture capital funding to $165 million. Blink Health is a technology platform that enables consumers to access the medications at affordable prices through over 57,000 pharmacies nationwide. EGS acted as counsel to Blink Health.
Catalyst Biosciences Inc. announced the closing of their Underwritten offering in the amount of $18,939,000. EG&S acted as counsel to the Underwriter.
SGOCO Group Ltd. announced the closing of their Registered Direct offering in the amount of $1,000,000. EG&S acted as counsel to the Investor.
EKSO Bionics Holdings, Inc. announced the closing of their Registered Direct offering in the amount of $11,719,597. EG&S acted as counsel to the Placement Agent.
ITUS Corporation announced the closing of its rights offering of common shares in the amount of $4,700,000. EG&S acted as counsel to ITUS.
Atossa Genetics Inc. announced the closing of their Underwritten offering in the amount of $4,397,500. EG&S acted as counsel to the Underwriter.
Dynatronics Corporation announced the closing of their PIPE in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
Biocept Inc. announced the closing of their Registered Direct offering in the amount of $9,296,672. EG&S acted as counsel to the lead Investor.
Douglas S. Ellenoff, a member of the Firm, wrote an article for LexisNexis; Lexis Practice Advisor titled "Market Trends: Crowdfunding."
Click here to read the article
Kayne Anderson Acquisition Corp. announced the closing of its initial public offering in the amount of $350,000,000. EG&S acted as counsel to Kayne Anderson.